Preview

Научно-практическая ревматология

Расширенный поиск

Энтезопатии при спондилоартритах

https://doi.org/10.47360/1995-4484-2021-316-325

Полный текст:

Аннотация

В статье представлены современные данные об эпидемиологии, патогенезе, клинических проявлениях, диагностике и терапии энтезопатий. Подробно рассмотрены подходы к объективизации оценки данной патологии, приведены современные клинические и ультразвуковые индексы. Также показаны особенности энтезопатий при заболеваниях, входящих в группу спондилоартритов.

Об авторах

Д. И. Абдулганиева
ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России; ГАУЗ «Республиканская клиническая больница Министерства здравоохранения Республики Татарстан»
Россия

420012, Казань, ул. Бутлерова, 49;
420064, Казань, Оренбургский тракт, 138



Э. Р. Кириллова
ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России; ГАУЗ «Республиканская клиническая больница Министерства здравоохранения Республики Татарстан»
Россия

420012, Казань, ул. Бутлерова, 49;
420064, Казань, Оренбургский тракт, 138



И. Ф. Файрушина
ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России; ГАУЗ «Республиканская клиническая больница Министерства здравоохранения Республики Татарстан»
Россия

420012, Казань, ул. Бутлерова, 49;
420064, Казань, Оренбургский тракт, 138



Г. Р. Гайнуллина
ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России; ГАУЗ «Городская клиническая больница № 7» г. Казани
Россия

420012, Казань, ул. Бутлерова, 49;
420103, Казань, ул. Маршала Чуйкова, 54



Р. З. Абдракипов
ГАУЗ «Республиканская клиническая больница Министерства здравоохранения Республики Татарстан»
Россия

420064, Казань, Оренбургский тракт, 138



Р. Г. Мухина
ГАУЗ «Городская клиническая больница № 7» г. Казани
Россия

420103, Казань, ул. Маршала Чуйкова, 54



Э. И. Мухаметшина
ФГАОУ ВО «Казанский (Приволжский) федеральный университет»
Россия

420043, Казань, ул. Чехова, 1а



Список литературы

1. Эрдес ШФ, Ребров АП, Дубинина ТВ, Бадокин ВВ, Бочкова АГ, Бугрова ОВ, и др. Спондилоартриты: современная терминология и определения. Терапевтический архив. 2019;91(5):84-88. doi: 10.26442/00403660.2019.05.000208

2. Румянцева ДГ, Эрдес ШФ. Аксиальный спондилоартрит: современный взгляд на концепцию и эволюцию болезни. Современная ревматология. 2019;13(4):4-10. doi: 10.14412/1996-7012-2019-4-4-10

3. Polachek A, Li S, Chandran V, Gladman DD. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: Incidence, prevalence, characteristics, and outcome. Arthritis Care Res. 2017;69(11):1685-1691. doi: 10.1002/acr.2317

4. Freeston JE, Coates LC, Helliwell PS, Hensor EM, Wakefield RJ, Emery P, et al. Is there subclinical enthesitis in early psoriatic arthritis? A clinical comparison with power doppler ultrasound. Arthritis Care Res. 2012;64:1617-1621. doi: 10.1002/acr.21733

5. Naredo E, Möller I, de Miguel E, Batlle-Gualda E, Acebes C, Brito E, et al. Ultrasound School of the Spanish Society of Rheumatology and Spanish ECO-APs Group. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology (Oxford). 2011; 50:1838-1848. doi: 10.1093/rheumatology/ker078

6. Kaeley GS, Eder L, Aydin SZ, Gutierrez M, Bakewell C. Enthesitis: A hallmark of psoriatic arthritis. Semin Arthritis Rheum. 2018;48(1):35-43. doi: 10.1016/j.semarthrit.2017.12.008

7. DeWinter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18(1):1-11. doi: 10.1186/s13075-016-1093-z

8. Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Rizzello F, et al. Case-control study on dactylitis, enthesitis, and anterior uveitis in spondyloarthritis associated with inflammatory bowel diseases: Role of coexistent psoriasis. J Rheumatol. 2017;44(9):1341-1346. doi: 10.3899/jrheum.161518

9. Karreman MC, Luime JJ, Hazes JM, Weel AEAM. The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: A systematic review and meta-analysis. J Crohns Colitis. 2016;75(2):334-339. doi: 10.1093/ecco-jcc/jjw199

10. D’Agostino MA, Olivieri I. Enthesitis. Best practice & research. Clin Rheumatol. 2006;20(3):473-486. doi: 10.1016/j.berh.2006.03.007

11. François RJ, Braun J, Khan MA. Entheses and enthesitis: a histopathologic review and relevance to spondyloarthritides. Curr Opin Rheumatol. 2001;13:255-264. doi: 10.1097/00002281-200107000-00003

12. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum. 1991;34:1218-1227. doi: 10.1002/art.1780341003

13. Sparado A, Iagnocco A, Perrotta FM, Modesti M, Scarno A, Valesini G. Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis. Rheumatology (Oxford). 2011;50:2080-2086. doi: 10.1093/rheumatology/ker284

14. Benjamin M, Kumai T, Milz S, Boszczyk BM, Boszczyk AA, Ralphs JR. The skeletal attachment of tendons – tendon “entheses”. Comp Biochem Physiol A Mol Integr Physiol. 2002;133(4):931-945. doi: 10.1016/s1095-6433(02)00138-1

15. Benjamin M, Moriggl B, Brenner E, Emery P, McGonagle D, Redman S. The “enthesis organ” concept: Why enthesopathies may not present as focal insertional disorders. Arthritis Rheum. 2004;50:3306-3313. doi: 10.1002/art.20566

16. McGonagle D, Stockwin L, Isaacs J, Emery P. An enthesitis based model for the pathogenesis of spondyloarthropathy: additive effects of microbial adjuvant and biomechanical factors at disease sites. Rheumatology (Oxford). 2001;28:2155-2159.

17. Huang B, Pathria M, Tadros A. Muscle – tendon – enthesis unit. Semin Musculoskelet Radiol. 2018;22(03):263-274. doi: 10.1055/s-0038-1641570

18. Benjamin M, McGonagle D. The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol. 2009;649:57-70. doi: 10.1007/978-1-4419-0298-6_4

19. McGonagle D. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol. 2009;23(1):9-13. doi: 10.1111/j.1468-3083.2009.03363.x

20. Emad Y, Ragab Y, Gheita T, Anbar A, Kamal H, Saad A, et al. Knee Enthesitis Working Group: Knee enthesitis and synovitis on magnetic resonance imaging in patients with psoriasis without arthritic symptoms. J Rheumatol. 2012;39:1979-1986. doi: 10.3899/jrheum.120301

21. Benjamin M, Toumi H, Ralphs JR, Bydder G, Best TM, Milz S. Where tendons and ligaments meet bone: attachment sites (“enthuses”) in relation to exercise and/or mechanical load. J Anat. 2006;208:471-490. doi: 10.15557/JoU.2015.0006

22. Benjamin M, Redman S, Milz S, Büttner A, Amin A, Moriggl B, et al. Adipose tissue at entheses: The rheumatological implications of its distribution. A potential site of pain and stress dissipation? Ann Rheum Dis. 2004;63(12):1549-1555. doi: 10.1136/ard.2003.019182

23. Sudoł-Szopińska I, Kwiatkowska B, Prochorec-Sobieszek M, Maśliński W. Enthesopathies and enthesitis. Part 1. Etiopathogenesis. J Ultrason. 2015;15(60):72-84. doi: 10.15557/JoU.2015.0006

24. Thomopoulos S, Kim HM, Rothermich SY, Biederstadt C, Das R, Galatz LM. Decreased muscle loading delays maturation of the tendon enthesis during postnatal development. J Orthop Res. 2007;25:1154-1163. doi: 10.1002/jor.20418

25. Jacques P, Lambrecht S, Verheugen E, Pauwels E, Kollias G, Armaka M, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73:437-445. doi: 10.1136/annrheumdis-2013-203643

26. McGonagle D, Marzo-Ortega H, O’Connor P, Gibbon W, Hawkey P, Henshaw K, et al. Histological assessment of the early enthesitis lesion in spondyloarthropathy. Ann Rheum Dis. 2002;61:534-537. doi: 10.1136/ard.61.6.534

27. Binks D, Matzelle M, Bergin D, Hodgson RJ, Tan AL, Gravallese EM, et al. The frequency of bone marrow oedema adjacent to the cruciate ligament peri-entheseal vascular channels in inflammatory and degenerative arthritis. Arthritis Rheum. 2013;65:25-26.

28. McGonagle D, Lories RJ, Tan AL, Benjamin M. The concept of a “synovio-entheseal complex” and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum. 2007;56:2482-2491. doi: 10.1002/art.22758

29. Paramarta JE, van der Leij C, Gofita I, Yeremenko N, van de Sande MG, de Hair MJ, et al. Peripheral joint inflammation in early onset spondyloarthritis is not specifically related to enthesitis. Ann Rheum Dis. 2014;73:735-740. doi: 10.1136/annrheumdis-2012-203155

30. van Duivenvoorde LM, Slobodin GM, Satumtira N, Dorris ML, Tak PP, Baeten DL, et al. Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2-microglobulin-transgenic rat model of spondylarthritis. Arthritis Rheum. 2012;64:3210-3219. doi: 10.1002/art.34600

31. Francois RJ, Gardner DL, Degrave EJ, Bywaters EG. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis: systematic study of specimens from patients and control subjects. Arthritis Rheum. 2000;43:2011-2410. doi: 10.1002/1529-0131(200009)43:9<2011::AIDANR12>3.0.CO;2-Y

32. Haroon M, Winchester R, Giles JT, Heffernan E, FitzGerald O. Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis. 2016;75:155-162. doi: 10.1136/annrheumdis-2014-205461

33. Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheum Int. 2006;26(7):663-668. doi: 10.1007/s00296-005-0044-9

34. Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat Commun. 2015;6:7146. doi: 10.1038/ncomms8146

35. Hacker G, Redecke V, Hacker H. Activation of the immune system by bacterial CpG-DNA. Immunology. 2002;105:245-251. doi: 10.1046/j.0019-2805.2001.01350.x

36. Jacques P, VanPraet L, Carron P, van den Bosch F, Elewaut D. Pathophysiology and role of the gastrointestinal system in spondyloarthritides. Rheum Dis Clin North Am. 2012;38:569-582. doi: 10.1016/j.rdc.2012.08.012

37. Yang L, Wang L, Wang X, Xian CJ, Lu H. A possible role of intestinal microbiota in the pathogenesis of ankylosing spondylitis. Int J Mol Sci. 2016;17(12):2126. doi: 10.3390/ijms17122126

38. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernández-Sueiro JL, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359-2364. doi: 10.1084/jem.180.6.2359

39. Beniwal P, Harrell L. The status of diagnostic markers for inflammatory bowel disease. Curr Gastroenterol Rep. 2010;12:479-484. doi: 10.1007/s11894-010-0145-9

40. Guerassimov A, Zhang Y, Banerjee S, Cartman A, Webber C, Esdaile J, et al. Autoimmunity to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis. Rheumatology (Oxford). 1998;25:1480-1484. doi: 10.1084/jem.180.6.2359

41. Shi SL, Ciurli C, Cartman A, Pidoux I, Poole AR, Zhang Y. Experimental immunity to the G1 domain of the proteoglycan versican induces spondylitis and sacroiliitis, of a kind seen in human spondylarthropathies. Arthritis Rheum. 2003;48:2903-2915. doi: 10.1002/art.11270

42. Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Inv. 2005;115:1571-1579. doi: 10.1172/JCI23738

43. Braem K, Carter S, Lories RJ. Spontaneous arthritis and ankylosis in male DBA/1 mice: further evidence for a role of behavioral factors in “stress-induced arthritis”. Biol Proced Online. 2012;14:10. doi: 10.1186/1480-9222-14-10

44. Wellcome Trust Case Control Consortium, Australo-AngloAmerican Spondylitis Consortium (TASC), Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329-1337. doi: 10.1038/ng.2007.17

45. Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, Grein J, et al. IL-23 induces spondyloarthropathy by acting on ROR-γt+CD3+CD4-CD8-entheseal resident T cells. Nat Med. 2012;18:1069-1076. doi: 10.1038/nm.2817

46. Lories RJ, McInnes IB. Primed for inflammation: Enthesisresident T cells. Nat Med. 2012;6:18(7):1018-1019. doi: 10.1038/nm.2854

47. Noordenbos T, Yeremenko N, Gofita I, van de Sande M, Tak PP, Caňete JD, et al. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum. 2012;64:99-109. doi: 10.1002/art.33396

48. Heuft-Dorenbosch L, Spoorenberg A, Tubergen A, Landewé R, van ver Tempel H, Mielants H, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis. 2003;62 (2):127-132. doi: 10.1136/ard.62.2.127

49. Mease PJ. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness TherapyFatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res. 2011;63(11):64-85. doi: 10.1002/acr.20577

50. Perrotta FM, Astorri D, Zappia M, Reginelli A, Brunese L, Lubrano E. An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment. Rheumatol Int. 2016;36:1579-1583. doi: 10.1007/s00296-016-3562-8

51. Эрдес ШФ, Бочкова АГ, Дубинина ТВ, Лапшина СА, Мясоутова ЛИ, Румянцева ОА, и др. Проект рабочей классификации анкилозирующего спондилита. Научнопрактическая ревматология. 2013;51(6):604-608. doi: 10.14412/1995-4484-2013-604-8

52. Kiris A, Kaya A, Ozgocmen S, Kocakoc E. Assessment of enthesitis in ankylosing spondylitis by power Doppler ultrasonography. Skeletal Radiol. 2006;35:522-528. doi: 10.1007/s00256-005-0071-3

53. Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis. 2002;61:905-910. doi: 10.1136/ard.61.10.905

54. Schett G, Lories R, D’Agostino M, Elewaut D, Kirkham B, Soriano ER, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017;13:731-741. doi: 10.1038/nrrheum.2017.188

55. Ruyssen-Witrand A, Jamard B, Cantagrel A, Nigon D, Loeuille D, Degboe Y, et al. Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort. RMD Open. 2017;9:1-8. doi: 10.1136/rmdopen-2017-000482

56. Milutinovic S, Radunovic G, Veljkovic K, Zlatanovic M, Damjanov N. Construct validity and sensitivity to change of Belgrade Ultrasound Enthesitis Score in patients with spondyloarthritis: A pilot study. Rheumatol Int. 2017;38(3):383-391. doi: 10.1007/s00296-017-3898-8

57. Eder L, Jayakar J, Thavaneswaran A, Haddad A, Chandran V, Salonen D, et al. Is the Madrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? J Rheumatol. 2014;41(3):466-472. doi: 10.3899/jrheum.130949

58. Alcalde M, Acebes JC, Cruz M, González-Hombrado L, HerreroBeaumont G, Sánchez-Pernaute O. A Sonographic Enthesitic Index of lower limbs is a valuable tool in the assessment of ankylosing spondylitis. Ann Rheum Dis. 2007;66(8):1015-1019. doi: 10.1136/ard.62.2.127

59. Terslev L, Naredo E, Iagnocco A, Balint PV, Wakefield RJ, Aegerter P, et al. Defining enthesitis in spondyloarthritis by ultrasound: results of a Delphi process and of a reliability reading exercise. Arthritis Care Res. 2014;66:741-748. doi: 10.1002/acr.22191

60. Sibel ZA, Omer K, Filippucci E, Atagunduz P, Akdogan A, Kalyoncu U, et al. Monitoring Achilles enthesitis in ankylosing spondylitis during TNF-α antagonist therapy: An ultrasound study. Rheumatology (Oxford). 2010;49(3):578-582. doi: 10.1093/rheumatology/kep410

61. de Miguel E, Cobo T, Muñoz-Fernández S, Naredo E, Usón J, Acebes JC, et al. Validity of enthesis ultrasound assessment in spondyloarthropathy. Ann Rheum Dis. 2009;68:169-174. doi: 10.1136/ard.2007.084251

62. McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. Lancet. 1998;352:1137-1140. doi: 10.1016/S0140-6736(97)12004-9

63. Eshed I, Bollow M, McGonagle DG, Tan AL, Althoff CE, Asbach P, et al. MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis. 2007;66(12):1553-1559. doi: 10.1136/ard.2007.070243

64. Mandl P, Navarro-Compán V, Terslev L, Aegerter P, van der Heijde D, D’Agostino MA, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015;74(7):1327-1339. doi: 10.1136/annrheumdis-2014-206971

65. Olivieri I, Giasi V, Scarano E, Gigliotti P, D’Angelo S, Padula A. A brief course of anti-TNF-α therapy can cure recurrent episodes of HLA-B27-associated severe and refractory heel enthesitis [letter]. Clin Exp Rheumatol. 2009;27:1057.

66. Elyoussfi S, Thomas BJ, Ciurtin C. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies. Rheumatol Int. 2016;36:603-612. doi: 10.1007/s00296-016-3436-0

67. Kavanaugh A, Mease PJ, Gomez-Reino JJ, Adebajo AO, Wollenhaupt J, Gladman DD, et al. Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Ann Rheum Dis. 2014;73(6):1020-1026. doi: 10.1136/annrheumdis-2013-205056

68. Mourad A, Gniadecki R. Treatment of dactylitis and enthesitis in psoriatic arthritis with biologic agents: A systematic review and metaanalysis. J Rheumatol. 2020;47(1):59-65. doi: 10.1136/annrheumdis-2013-205056

69. van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J. Efficacy and safety of adalimumab in patients with ankylosing spondylitis. Results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2006;54:2136-2146. doi: 10.1002/art.21913

70. Sterry W, Ortonne JP, Kirkham B, Brocq O, Robertson D, Pedersen RD, et al. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial. BMJ. 2010;340:147. doi: 10.1136/bmj.c147

71. Guillot X, Prati C, Sondag M, Wendling D. Etanercept for treating axial spondyloarthritis. Expert Opin Biol Ther. 2017;17(9):1173-1181. doi: 10.1080/14712598.2017.1347156

72. Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis. 2005;64:1150-1157. doi: 10.1136/ard.2004.032268

73. Heldmann F, Baraliakos X, Kiltz U. Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): Long-term extension over 7 years with focus on clinical efficacy and safety. Clin Exp Rheumatol. 2016;34(2):184-190.

74. Moreno M, Gratacós J, Torrente-Segarra V, Sanmarti R, Morlà R, Pontes C, et al. Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study. Arthritis Res Ther. 2019;21(1):88. doi: 10.1186/s13075-019-1873-3

75. Mease PJ, Fleischmann R, Deodhar AA, Wollenhaupt J, Khraishi M, Kielar D, et al. Effect of certolizumabpegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann Rheum Dis. 2014;73(1):48-55. doi: 10.1136/annrheumdis-2013-203696

76. Kavanaugh A, McInnes I, Mease P, Krueger GG, Gladman D, Gomez-Reino J, et al. Golimumab, a new human tumor necrosis factor alpha antibody, administered every 4 weeks as a subcutaneous injection in psoriatic arthritis: 24-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum. 2009;60(4):976-986. doi: 10.1002/art.24403

77. Deodhar A, Gensler LS, Kay J, Maksymowych WP, Haroon N, Landewé R, et al. A fifty-two-week, randomized, placebo-controlled trial of certolizumab pegol in nonradiographic axial spondyloarthritis. Arthritis Rheum. 2019;71(7):1101-1111. doi: 10.1002/art.40866

78. Lekpa FK, Poulain C, Wendling D, Soubrier M, de Bandt M, Berthelot JM, et al. Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study. Arthritis Res Ther. 2012;14:R53. doi: 10.1186/ar3766

79. Song IH, Heldmann F, Rudwaleit M, Listing J, Appel H, HaugRost I, et al. One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare. Ann Rheum Dis. 2013;72:305-306. doi: 10.1136/annrheumdis-2012-201926

80. Jethwa H, Bowness P. The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: New advances and potentials for treatment. Clin Exp Immunol. 2016;183(1):30-36. doi: 10.1111/cei.12670

81. Nadon V, Moltó A, Etcheto A, Bessette L, Michou L, D’Agostino MA, et al. Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort. Clin Exp Immunol. 2019;37(4):561-565. doi: 10.1136/annrheumdis-2018-eular.4510

82. Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura AcostaFelquer M, Armstrong AW, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68:1060-1071. doi: 10.1002/art.39573

83. Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, et al. Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Arthritis Care Res. 2017;69:1692-1699. doi: 10.1002/acr.23249

84. Gutierrez M, Filippucci E, de Angelis R, Salaffi F, Filosa G, Ruta S, et al. Subclinical entheseal involvement in patients with psoriasis: an ultrasound study. Semin Arthritis Rheum. 2011;40:407-412. doi: 10.1016/j.semarthrit.2010.05.009

85. Tinazzi I, McGonagle D, Biasi D, Confente S, Caimmi C, Girolomoni G, et al. Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J Rheumatol. 2011;38:2691-2692. doi: 10.3899/jrheum.110505

86. Aydin SZ, Ash ZR, Tinazzi I, Castillo-Gallego C, Kwok C, Wilson C, et al. The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Ann Rheum Dis. 2013;72:992-995. doi: 10.1136/annrheumdis-2012-201617

87. Ficjan A, Husic R, Gretler J, Lackner A, Graninger WB, Gutierrez M, et al. Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score). Arthritis Res Ther. 2014;16:476. doi: 10.1186/s13075-014-0476-2

88. Садыгова ГГ. Внекишечные проявления воспалительных заболеваний кишечника: артропатии и артриты. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(6):101-105. doi: 10.22416/1382-4376-2016-26-6-101-105

89. Olivieri I, Cantini F, Castiglione F, Felice C, Gionchetti P, Orlando A, et al. Italian expert panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun Rev. 2014;13:822-830. doi: 10.1016/j.autrev.2014.04.003

90. Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum. 2001;44:2728-2736. doi: 10.1002/1529-0131(200112)44:12<2728::aid-art459>3.0.co;2-8

91. Кузин АВ. Поражение суставов и позвоночника у больных с воспалительными заболеваниями кишечника. Современная ревматология. 2016;10(2):78-82. doi: 10.14412/1996-7012-2016-2-78-82

92. Arvikar SL, Fisher MC. Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med. 2011;4:123-131. doi: 10.1007/s12178-011-9085-8

93. Voulgari PV. Rheumatological manifestations in inflammatory bowel disease. Ann Gastroenterol. 2011;24(3):173-180.

94. Bandinelli F, Milla M, Genise S, Giovannini L, Bagnoli S, Candelieri A, et al. Ultrasound discloses entheseal involvement in inactive and low active inflammatory bowel disease without clinical signs and symptoms of spondyloarthropathy. Rheumatology (Oxford). 2011;50(7):1275-1279. doi: 10.1093/rheumatology/keq447

95. Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, et al. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol. 2001;36(12):1307-1313. doi: 10.1080/003655201317097173

96. Lanna CC, Ferrari M, Rocha SL, Nascimento E, de Carvalho MA, da Cunha AS. A cross-sectional study of 130 Brazilian patients with Crohn’s disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol. 2008;27(4):503-509. doi: 10.1007/s10067-007-0797-5

97. Al-Jarallah K, Shehab D, Al-Azmi W, Al-Fadli A. Rheumatic complications of inflammatory bowel disease among Arabs: A hospital-based study in Kuwait. Int J Rheum Dis. 2013;16(2):134-138. doi: 10.1111/j.1756-185X.2012.01811.x


Для цитирования:


Абдулганиева Д.И., Кириллова Э.Р., Файрушина И.Ф., Гайнуллина Г.Р., Абдракипов Р.З., Мухина Р.Г., Мухаметшина Э.И. Энтезопатии при спондилоартритах. Научно-практическая ревматология. 2021;59(3):316-325. https://doi.org/10.47360/1995-4484-2021-316-325

For citation:


Abdulganieva D.I., Kirillova E.R., Fairushina I.F., Gaynullina G.R., Abdrakipov R.Z., Mukhina R.G., Mukhametshina E.I. Enthesopathy in spondyloarthritis: the literature review. Rheumatology Science and Practice. 2021;59(3):316-325. (In Russ.) https://doi.org/10.47360/1995-4484-2021-316-325

Просмотров: 135


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)